Affiliation:
1. Motor Neuron Disease Unit, Division of Neuromuscular Diseases, Federal University of São Paulo (UNIFESP), São Paulo 04039-060, SP, Brazil
Abstract
A 38-year-old Brazilian man presented with slowly progressive quadriparesis since age 11 years. He progressed over 15 years with symptoms restricted to the lower limbs, and since then, with a progressive compromise of the upper limbs. His deceased brother had a similar clinical presentation. Examination showed spastic dysarthria, global amyotrophy, brisk tendon reflexes in the lower limbs, symmetrical quadriparesis, and fasciculations in the four limbs. Neurophysiological studies disclosed acute and chronic signs of denervation and chronic reinnervation involving the cervical, thoracic, and lumbosacral myotomes, with normal sensory conduction study. Fibrillation potentials, fasciculations, and positive sharp waves involved mainly the upper limbs. A diagnosis of long-standing juvenile-onset motor neuronopathy was established. Genetic testing identified the possibly pathogenic variant c.3G>T (p.Met1?) in homozygosity in the COQ7 gene. This report highlights the importance of considering a potentially treatable metabolic dysfunction as the primary mechanism in cases of juvenile motor neuron disease.
Reference12 articles.
1. Motor neuron disease in inherited neurometabolic disorders;Souza;Rev. Neurol.,2018
2. Jacquier, A., Theuriet, J., Fontaine, F., Mosbach, V., Lacoste, N., Ribault, S., Risson, V., Carras, J., Coudert, L., and Simonet, T. (2022). Homozygous COQ7 mutation: A new cause of potentially treatable distal hereditary motor neuropathy. Brain, awac453. Epub ahead of print.
3. Novel homozygous variant in COQ7 in siblings with hereditary motor neuropathy;Smith;Neurol. Genet.,2023
4. A novel COQ7 mutation causing primarily neuromuscular pathology and its treatment options;Wang;Mol. Genet. Metab. Rep.,2022
5. Pathogenicity of two COQ7 mutations and responses to 2,4-dihydroxybenzoate bypass treatment;Wang;J. Cell. Mol. Med.,2017